Black Rock Inc. Eton Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 282,389 shares of ETON stock, worth $2.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

282,389

Previous 282,952 0.2%

Holding current value

$2.95 Million

Previous $1.06 Million 12.44%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.06 - $3.75 $1,722 - $2,111	-563 Reduced 0.2%	282,389 $929,000
Q1 2024 May 10, 2024	SELL	$3.48 - $5.03 $4,485 - $6,483	-1,289 Reduced 0.45%	282,952 $1.06 Million
Q4 2023 Feb 13, 2024	SELL	$3.45 - $4.66 $3,225 - $4,357	-935 Reduced 0.33%	284,241 $1.24 Million
Q3 2023 Nov 13, 2023	SELL	$2.55 - $5.63 $33,274 - $73,465	-13,049 Reduced 4.38%	285,176 $1.19 Million
Q2 2023 Aug 11, 2023	BUY	$3.32 - $4.04 $18,459 - $22,462	5,560 Added 1.9%	298,225 $1.04 Million
Q1 2023 May 12, 2023	BUY	$2.89 - $4.1 $5,531 - $7,847	1,914 Added 0.66%	292,665 $1.13 Million
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $1,191 - $1,917	590 Added 0.2%	290,751 $819,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $3.03 $3,166 - $4,702	-1,552 Reduced 0.53%	290,161 $610,000
Q2 2022 Aug 12, 2022	SELL	$2.55 - $4.38 $12,306 - $21,137	-4,826 Reduced 1.63%	291,713 $764,000
Q1 2022 May 12, 2022	SELL	$3.43 - $4.69 $8,242 - $11,270	-2,403 Reduced 0.8%	296,539 $1.29 Million
Q4 2021 Feb 10, 2022	SELL	$3.66 - $6.59 $7,155 - $12,883	-1,955 Reduced 0.65%	298,942 $1.28 Million
Q3 2021 Nov 09, 2021	SELL	$4.2 - $6.26 $676 - $1,007	-161 Reduced 0.05%	300,897 $1.52 Million
Q2 2021 Aug 11, 2021	BUY	$5.71 - $8.85 $1.72 Million - $2.66 Million	301,058 New	301,058 $1.86 Million

Others Institutions Holding ETON

# of Institutions

Shares Held

9.44M

Call Options Held

261K

Put Options Held

500

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $264M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account